Lucrecia Yáñez, MD, PhD

Hematologist
Hospital Universitario Marqués de Valdecilla, Spain

Poster(s):

• 1004 - Ubiquitin-like post-translational modifications may modulate the pathogenesis of chronic lymphocytic leukemia mediated by RRAS2

• 1106 - Genomic characterization of chronic lymphocytic leukemia patients with TP53 alterations from a spanish real-world cohort treated with targeted agents

• 1302 - Pevonedistat Enhances the Cytotoxic Effect of Rohinitib on B Cells of Chronic Lymphocytic Leukemia

• 1306 - Distinctive Features in NF-kB Regulation Favor a Synergistic Action of Pevonedistat and Laduviglusib on B Cells of Chronic Lymphocytic Leukemia